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Background
The prevalence of gestational diabetes (GD) in Brazil
can exceed 18% when applied the current WHO diag-
nostic criteria. The importance of the GD treatment in
reducing severe outcomes of perinatal maternal morbid-
ity and has been shown in randomized clinical trials.
Therapeutic options for the GD have included oral anti-
diabetic agents glibenclamide (GB) and metformin (MF)
showed Results of safety and efficacy similar to insulin.
Objective
To analyze the effects of the use of GB and MF in the
treatment of GD in pregnant women at a specialized
clinic in HCPA in a randomized open-label study.
Materials and methods
Eighty-one women diagnosed with GD and drug treat-
ment indication were randomized. The initial dose of
GB was 2.5 mg/day with an increase of 2.5 mg next
week and new increments of 5 mg/week to achieve gly-
cemic targets or maximum dose (20mg/day); MF is an
initial dose of 500mg to 500mg increments every 3 days
to obtain the target or maximum dose of 2.5 g/day.
Results
Thirty-six patients were randomized to the MT group
and 45 for the GB group. The slurry treatment rate
were 22.9% and 54.5%, respectively MP and GB group
(p=0.006). Reasons for discontinuation of medications is
hypoglycemia: 2.9% and 38.6% (p <0.001), respectively
MF and GB group; not glycemic compensation: 2.9%
and 13.6% (p=0.095), respectively MF and G groups);
and gastric intolerance: 17.1% and 2.3% (p=0.021)
respectively MF group and GB.
Conclusion
Current evidence suggests that oral anti-diabetics are
safe and effective for glycemic control in GD. This study
was prematurely terminated by the high incidence of
hypoglycemia in the GB group, considered ethically
unacceptable by an independent review committee. MF
was well tolerated and showed up as the first oral option
in drug treatment of hyperglycemia in pregnancy.
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Figure 1 Patients' results medications.
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